Anzupgo is used to treat moderate to severe chronic hand eczema (a long-term condition where the skin of the hands is itchy, red and dry) in adults who cannot use corticosteroids applied to the skin or in whom such corticosteroids do not work well enough. Anzupgo contains the active substance delgocitinib.
Therapeutic Indication
### Therapeutic indication Anzupgo is indicated for the treatment of moderate to severe chronic hand eczema (CHE)
Therapeutic Area (MeSH)
ATC Code
D11AH11
ATC Item
delgocitinib
Pharmacotherapeutic Group
Other dermatological preparations
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Delgocitinib | N/A | Delgocitinib |
EMA Name
Anzupgo
Medicine Name
Anzupgo
Aliases
N/ANo risk management plan link.
